|
**Overview**: Folate Red Blood Cell Panel**Introduction**: The Folate Red Blood Cell Panel is a diagnostic tool designed to assess folate deficiency using whole blood samples. In India, folate deficiency is common (~20-40 percent in pregnant women and children) due to poor diet, malabsorption, and alcoholism, contributing to megaloblastic anemia, neural tube defects, and growth retardation. RBC folate reflects long-term status better than serum. High morbidity from underdiagnosis in rural/low-SES populations, limited nutritional labs, delayed supplementation leading to anemia or birth defects. Per biochemistry practices aligned with ICMR and National Nutrition Monitoring Bureau guidelines, the test employs spectrophotometry for RBC and serum folate over 1-2 days with high accuracy, valuable for nutritional assessment in anemia or pregnancy. This diagnostic falls under nutritional screening and targets patients with macrocytic anemia or pregnancy risk, addressing accurate detection to guide folic acid supplementation. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise identification and reducing anemia/birth defect burden. Its whole blood-based approach ensures reliable RBC folate measurement.**Other Names**: Folate RBC Pnl.**FDA Status**: FDA approved, CLIA certified for biochemistry, compliant with 2025 standards.**Historical Milestone**: RBC folate standard; in India, used in anemia/pregnancy programs.**Purpose**: The test assesses 2 parameters including RBC folate to guide deficiency evaluation, detect nutritional status, inform supplementation.**Test Parameters**: 1. RBC Folate, 2. Serum Folate.**Pretest Condition**: Fasting 10-12 hours recommended; patients should report anemia or pregnancy.**Specimen**: 3 mL whole blood in 1 EDTA tube, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 48 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: Not applicable (fresh sample preferred for analysis).**Medical History**: Patients should provide details on diet, pregnancy, anemia symptoms.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of untreated deficiency including anemia, benefits of early detection, and minimal discomfort from blood draw.**Procedural Considerations**: The test involves sample processing using spectrophotometry by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis, or recent supplementation can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Low RBC folate indicates deficiency, necessitating specialist input. Normal may require follow-up in high-risk.**Specialist Consultation**: Hematologists or obstetricians should be consulted for management.**Additional Supporting Tests**: B12, homocysteine for confirmation.**Test Limitations**: Affected by recent intake; comprehensive approach required.**References**: Indian Journal of Community Medicine 2024, Nutrition Studies India 2023. |
